SODIUM LABELING, PEDIATRIC DOSING FOR COUGH/COLD PRODUCTS ARE POTENTIAL FUTURE TOPICS FOR OTC ADVISORY CMTE., FDA’s BOTSTEIN SAYS; DOXYLAMINE ISSUE ALSO CITED